Richard W Pascoe - Net Worth and Insider Trading
Richard W Pascoe Net Worth
The estimated net worth of Richard W Pascoe is at least $155,500 dollars as of 2024-05-08. Richard W Pascoe is the CEO of Zevra Therapeutics Inc and owns about 29,973 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $155,260. Richard W Pascoe is also the President, CEO & Director of Histogen Inc and owns about 1,500 shares of Histogen Inc (HSTO) stock worth over $240. Details can be seen in Richard W Pascoe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard W Pascoe has not made any transactions after 2023-03-09 and currently still holds the listed stock(s).
Transaction Summary of Richard W Pascoe
Richard W Pascoe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard W Pascoe owns 4 companies in total, including Zevra Therapeutics Inc (ZVRA) , Histogen Inc (HSTO) , and Seelos Therapeutics Inc (SEEL) among others .
Click here to see the complete history of Richard W Pascoe’s form 4 insider trades.
Insider Ownership Summary of Richard W Pascoe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | director |
| HSTO | Histogen Inc | 2021-03-30 | director & See Remarks |
| SEEL | Seelos Therapeutics Inc | 2018-11-30 | director & CEO & Secretary |
 | | 2008-04-11 | Senior VP & COO |
Richard W Pascoe Latest Holdings Summary
Richard W Pascoe currently owns a total of 2 stocks. Among these stocks, Richard W Pascoe owns 29,973 shares of Zevra Therapeutics Inc (ZVRA) as of March 9, 2023, with a value of $155,260 and a weighting of 99.85%. Richard W Pascoe also owns 1,500 shares of Histogen Inc (HSTO) as of March 30, 2021, with a value of $240 and a weighting of 0.15%.
Latest Holdings of Richard W Pascoe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2023-03-09 | 29,973 | 5.18 | 155,260 |
| HSTO | Histogen Inc | 2021-03-30 | 1,500 | 0.16 | 240 |
Holding Weightings of Richard W Pascoe
Richard W Pascoe Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard W Pascoe has made a total of 5 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 10,000 shares on March 9, 2023, which cost Richard W Pascoe around $42,000.
According to the SEC Form 4 filings, Richard W Pascoe has made a total of 2 transactions in Histogen Inc (HSTO) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Histogen Inc is the acquisition of 1,000 shares on March 30, 2021, which cost Richard W Pascoe around $22,800.
Insider Trading History of Richard W Pascoe
- 1
Richard W Pascoe Trading Performance
GuruFocus tracks the stock performance after each of Richard W Pascoe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard W Pascoe is 5.12%. GuruFocus also compares Richard W Pascoe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard W Pascoe within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard W Pascoe's insider trading performs compared to the benchmark.
Performance of Richard W Pascoe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.28 | | | | | |
| Relative Return to S&P 500(%) | -0.51 | | | | | |
Richard W Pascoe Ownership Network
Richard W Pascoe Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Richard W Pascoe is the director of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , VP Fin & Corp Controller R. Laduane Clifton , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Richard W Pascoe made 2 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 19,500. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 6,100 shares made by R. Laduane Clifton , a net purchase of 3,500 shares made by Joshua Schafer , and a net purchase of 1,000 shares made by Watton Corey Michael .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 77,819 shares were bought by its insiders, resulting in a net purchase of 77,819 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Richard W Pascoe Mailing Address
Above is the net worth, insider trading, and ownership report for Richard W Pascoe. You might contact Richard W Pascoe via mailing address: C/o Seelos Therapeutics, Inc., 300 Park Avenue, 12th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
